# HPPH and PDT for Pleural Malignancy

> **NCT01673074** · PHASE1 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 37 (estimated)

## Conditions studied

- Pleural Malignancy

## Interventions

- **DRUG:** (PDT) Photodynamic therapy

## Key facts

- **NCT ID:** NCT01673074
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-10-08
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673074, "HPPH and PDT for Pleural Malignancy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01673074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*